Rajangam Kanya's Form 4 filing
Senti Biosciences Holdings, Inc. (SNTI) · filed Feb 6, 2025
- Accession no.
- 0001854270-25-000002
- Filed
- Feb 6, 2025
- Trade date
- Feb 4-6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $6.07K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rajangam KanyaCIK 0001816676 | Officer (Pres. & Chief Med. & Dev. Off.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | Common Stock | SSaleDisposed | −1,297 | $4.07 | −$5,278.79 | 8,803 | Direct | |
| Feb 6, 2025 | Common Stock | SSaleDisposed | −182 | $4.37 | −$795.34 | 8,621 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.